Chugai Pharmaceutical Co., Ltd.

TSE:4519 Stock Report

Market Cap: JP¥8.0t

Chugai Pharmaceutical Management

Management criteria checks 3/4

Chugai Pharmaceutical's CEO is Osamu Okuda, appointed in Mar 2020, has a tenure of 4.08 years. total yearly compensation is ¥298.00M, comprised of 36.2% salary and 63.8% bonuses, including company stock and options. directly owns 0.01% of the company’s shares, worth ¥766.37M. The average tenure of the management team and the board of directors is 4.3 years and 1.1 years respectively.

Key information

Osamu Okuda

Chief executive officer

JP¥298.0m

Total compensation

CEO salary percentage36.2%
CEO tenure4.1yrs
CEO ownership0.01%
Management average tenure4.3yrs
Board average tenure1.1yrs

Recent management updates

Recent updates

Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 26
Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

Mar 01
Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

CEO Compensation Analysis

How has Osamu Okuda's remuneration changed compared to Chugai Pharmaceutical's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

JP¥326b

Dec 31 2023n/an/a

JP¥325b

Sep 30 2023n/an/a

JP¥337b

Jun 30 2023n/an/a

JP¥327b

Mar 31 2023n/an/a

JP¥316b

Dec 31 2022JP¥298mJP¥108m

JP¥374b

Sep 30 2022n/an/a

JP¥371b

Jun 30 2022n/an/a

JP¥389b

Mar 31 2022n/an/a

JP¥387b

Dec 31 2021JP¥252mJP¥85m

JP¥303b

Sep 30 2021n/an/a

JP¥256b

Jun 30 2021n/an/a

JP¥231b

Mar 31 2021n/an/a

JP¥211b

Dec 31 2020JP¥84mJP¥40m

JP¥215b

Compensation vs Market: Osamu's total compensation ($USD1.90M) is about average for companies of similar size in the JP market ($USD1.58M).

Compensation vs Earnings: Osamu's compensation has been consistent with company performance over the past year.

CEO

Osamu Okuda (60 yo)

4.1yrs

Tenure

JP¥298,000,000

Compensation

Dr. Osamu Okuda serves as Representative Director and President at Chugai Pharmaceutical Co., Ltd. since March 30, 2020 and its Chief Executive Officer since March 23, 2021. Dr. Okuda served as Chief Opera...

Leadership Team

NamePositionTenureCompensationOwnership
Osamu Okuda
President4.1yrsJP¥298.00m0.0096%
¥ 766.4m
Toshiaki Itagaki
Head of Finance Supervisory Division6yrsno data0.0012%
¥ 97.4m
Toshiya Sasai
Executive of Investor Relations Group & Corporate Communications Departmentno datano datano data
Shinji Hidaka
Executive VP and Head of Marketing & Sales Division4.3yrsno datano data
Junichi Ebihara
Executive Vice President3.3yrsno datano data
Yoshiaki Ohashi
SVP & Full-time Audit Supervisory Board Member9.3yrsno data0.0030%
¥ 237.9m
Tetsuya Yamaguchi
Executive VP and Head of Project4.3yrsno datano data
Yoshiyuki Yano
Executive Vice Presidentno datano datano data
Satoko Shisai
Executive VP & Head of Digital Transformation Unitno datano datano data
Shigehiro Yamada
Head of Sustainability Department and Full-Time Audit & Supervisory Board Memberno datano data0.000060%
¥ 4.8m
Tomoyuki Igawa
Associate VP & Head of Translational Research Divisionno datano datano data
Kaori Ouchi
VP & Head of Drug Safety Division3.8yrsno datano data

4.3yrs

Average Tenure

60yo

Average Age

Experienced Management: 4519's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Osamu Okuda
President4.1yrsJP¥298.00m0.0096%
¥ 766.4m
Yoshiaki Ohashi
SVP & Full-time Audit Supervisory Board Member3.1yrsno data0.0030%
¥ 237.9m
Shigehiro Yamada
Head of Sustainability Department and Full-Time Audit & Supervisory Board Member1.1yrsno data0.000060%
¥ 4.8m
Hitoshi Iikura
VP, Head of Research Division & Directorless than a yearno datano data
Iwaaki Taniguchi
Senior VP and Head of Financeless than a yearno data0.00012%
¥ 9.6m
Osamu Nagayama
Honorary Chairman & Senior Advisor4.1yrsJP¥211.00mno data
Franz Humer
Member of the International Advisory Councilno datano datano data
Victor Halberstadt
Member of the International Advisory Councilno datano datano data
William A. Burns
Member of the International Advisory Councilno datano datano data
Henry Nordhoff
Chairman of the International Advisory Councilno datano datano data
Fumio Tateishi
Outside Independent Director1.1yrsno datano data
Teresa A. Graham
Director1.1yrsno datano data

1.1yrs

Average Tenure

63yo

Average Age

Experienced Board: 4519's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.